🔎 Trials Near Me

Inicio › Cáncer (todos los tipos) › Ohio

Ensayos clínicos de Cáncer (todos los tipos) en Ohio

85 estudios sobre Cáncer (todos los tipos) buscan participantes en Ohio.

Ciudades en Ohio

Texto oficial del estudio (inglés)

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

  • Nationwide Children's Hospital, Columbus
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 12 nov 2026 · NCT06423950

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • University Of Cincinnati Medical Center /ID# 251746, Cincinnati
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT05650632

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Cleveland Clinic, Cleveland
  • The Ohio State University, Department of Psychiatry, Columbus
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT07002034

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • OhioHealth O'Bleness Hospital, Athens
  • UHHS-Chagrin Highlands Medical Center, Beachwood
  • Geauga Hospital, Chardon
  • y 26 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT06580314

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • The Ohio State University, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07195591

Pan Tumor Rollover Study

  • Oncology Hematology Care, Cincinnati
  • The Ohio University, Columbus
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT03899155

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Miami Valley Hospital South, Centerville
  • USO - Oncology Hematology Care, Cincinnati
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care

  • Case Comprehensive Cancer Center, Cleveland
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06481774

Preparing for Life and Academics for Young Childhood Cancer Survivors

  • Nationwide Children's Hospital, Columbus
Reclutando
Todas las edades · Todos los sexos · Actualizado el 3 nov 2026 · NCT06769334

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

  • Gabrail Cancer & Research Center, Canton
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT05856981

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • Oncology Hematology Care, Inc., Cincinnati
  • University Hospitals of Cleveland, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • y 1 más
ReclutandoFase 2/3
Todas las edades · Todos los sexos · Actualizado el 2 nov 2026 · NCT03435796

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

  • GSK Investigational Site, Columbus
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06796907

Visugromab in Cachexia International Trial

  • Cleveland Clinic Avon Hospital, Avon
  • Cleveland Clinic (Main Campus), Cleveland
  • Cleveland Clinic Fairview Hospital, Fairview
  • y 1 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07112196

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • The Ohio State University Wexner Medical Center, Columbus
ReclutandoFase 3
Edades de 18 a 71 · Todos los sexos · Actualizado el 30 oct 2026 · NCT07504458

Met Non Small Cell Cancer Registry (MOMENT)

  • The Ohio State University Wexner Medical Center, Columbus
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 29 oct 2026 · NCT05376891

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

  • University Hospitals - UH Cleveland Medical Center, Cleveland
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT07094204

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

  • Nationwide Children's Hospital, Columbus
ReclutandoFase 2
Edades de 1 a 26 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07680439

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

  • Oncology Hematology Care Clinical Trials, LLC, Fairfield
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07566156

Collection of Tissue Samples for Cancer Research

  • Ohio State University, Columbus
ReclutandoEstudio observacional
2 Months · Todos los sexos · Actualizado el 27 oct 2026 · NCT00900198

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • The Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT04981119

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT02984761

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • The Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 20 oct 2026 · NCT07103018

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

  • Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
  • The Ohio State University /ID# 271336, Columbus
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06892522

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Case Western, Cleveland
  • Taylor Cancer Research Center, Maumee
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT05382559

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Miami Valley Hospital South, Centerville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT05386108

Suprachoroidal Administration in Subjects With Metastases to the Choroid

  • Cleveland Clinic, Cole Eye Institute, Cleveland
  • OH State Wexner Medical Center, Havener Eye Institute, Columbus
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT06643884

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
  • Cleveland Clinic, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT05919264

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Cleveland Clinic, Cleveland
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT03328078

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT06979596

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

  • University of Cincinnati Medical Center. /ID# 278925, Cincinnati
  • University Hospitals Cleveland Medical Center /ID# 279601, Cleveland
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 1 oct 2026 · NCT07024784

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • University Hospitals Cleveland Medical Center, Cleveland
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07192471

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • Ohio State University, Columbus
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05874921

Registry Study for Radiation Therapy Outcomes

  • University of Cincinnati Medical Center, Cincinnati
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 29 sept 2026 · NCT01255748

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

  • Investigative Site, Canton
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06881992

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Reclutando
Edades de 15 a 24 · Todos los sexos · Actualizado el 24 sept 2026 · NCT07223463

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Oncology Hematology Care - Fairfield /ID# 280641, Fairfield
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • University of Cincinnati Medical Center, Cincinnati
  • Kettering Health, Kettering
  • West Chester Hospital, West Chester
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT02693535

Statins to Prevent Cancer Associated Blood Clots

  • Cleveland Clinic Foundation, Cleveland
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07303816

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.